Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

May 2016

Feature

From the Field
05/06/2016
Bruce Feinberg, DO
Monica Lingam, MS
Bing-E Xu, PhD
Abstract: Clinical pathways are a critical structural element in the effort to reduce variation in health care as well as to make costs and outcomes more predictable, measurable, and accountable. A mock clinical...
Abstract: Clinical pathways are a critical structural element in the effort to reduce variation in health care as well as to make costs and outcomes more predictable, measurable, and accountable. A mock clinical...
...
05/06/2016
Journal of Clinical Pathways
Research Reports
05/06/2016
Jonathan Graham, BS
Stephanie Earnshaw, PhD
Jonathan Lim, BS, MS, MSc
Rakesh Luthra, MS
Rohit Borker, PhD
Abstract: A decision model was developed to compare the cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non–small cell lung cancer (NSCLC) with epidermal growth...
Abstract: A decision model was developed to compare the cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non–small cell lung cancer (NSCLC) with epidermal growth...
...
05/06/2016
Journal of Clinical Pathways

Column

Counterpoint
05/06/2016
George Dahlman
Regulatory action has been taken to address the problem of drug shortages for pediatric cancer patients. However, there is still more work to be done. During 2010 and 2011, the news headlines were filled with...
Regulatory action has been taken to address the problem of drug shortages for pediatric cancer patients. However, there is still more work to be done. During 2010 and 2011, the news headlines were filled with...
...
05/06/2016
Journal of Clinical Pathways
Viewpoint
05/06/2016
Yoram Unguru, MD, MS, MA
Shortages of life-saving chemotherapy agents and supportive care drugs have presented physicians treating children with cancer with difficult decisions regarding drug allocation and prioritization. Guidelines...
Shortages of life-saving chemotherapy agents and supportive care drugs have presented physicians treating children with cancer with difficult decisions regarding drug allocation and prioritization. Guidelines...
...
05/06/2016
Journal of Clinical Pathways
Pharma Insights
05/06/2016
David Parker, PhD
Larry Blandford, PharmD—Column Editor
We are pleased to present the second installment in our recurring column, Pharma Insights. This month we take a look at an interesting twist in how the use of complementary and companion diagnostics is playing out in...
We are pleased to present the second installment in our recurring column, Pharma Insights. This month we take a look at an interesting twist in how the use of complementary and companion diagnostics is playing out in...
We are...
05/06/2016
Journal of Clinical Pathways
Clinical Pathways GPS
05/06/2016
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Scott Guerin, PhD
Seth Gordon, MBA
The concept of the Triple Aim—improving the experience of care, reducing the costs of care, and improving the health of populations—is increasingly becoming important to drug manufacturers, who must demonstrate how...
The concept of the Triple Aim—improving the experience of care, reducing the costs of care, and improving the health of populations—is increasingly becoming important to drug manufacturers, who must demonstrate how...
The...
05/06/2016
Journal of Clinical Pathways

Insights

Interview
05/06/2016
Enacted in March of 2010, the Affordable Care Act (ACA) aimed to provide Americans with better health security through comprehensive health insurance reforms.1 Since then, the ACA has helped to significantly reduce...
Enacted in March of 2010, the Affordable Care Act (ACA) aimed to provide Americans with better health security through comprehensive health insurance reforms.1 Since then, the ACA has helped to significantly reduce...
...
05/06/2016
Journal of Clinical Pathways

Department

Research in Review
05/06/2016
JCP Editors
As pathways become more ingrained in the everyday care of patients with various diseases, Andrew R Bunchert, MD, and Gabriella A Butler, MSN, RN, health care professionals at the Children’s Hospital of Pittsburgh...
As pathways become more ingrained in the everyday care of patients with various diseases, Andrew R Bunchert, MD, and Gabriella A Butler, MSN, RN, health care professionals at the Children’s Hospital of Pittsburgh...
As...
05/06/2016
Journal of Clinical Pathways
Research in Review
05/06/2016
JCP Editors
A study of image-guided percutaneous liver biopsy (PLB) in patients with hepatocellular carcinoma has found that the procedure is increasingly being used in recent years despite safety concerns as well as rising...
A study of image-guided percutaneous liver biopsy (PLB) in patients with hepatocellular carcinoma has found that the procedure is increasingly being used in recent years despite safety concerns as well as rising...
...
05/06/2016
Journal of Clinical Pathways
Research in Review
05/06/2016
JCP Editors
Results from a study evaluating different tools intended to measure patient-reported health-related quality of life (HRQoL) in patients with breast cancer suggest that the Functional Assessment of Cancer...
Results from a study evaluating different tools intended to measure patient-reported health-related quality of life (HRQoL) in patients with breast cancer suggest that the Functional Assessment of Cancer...
...
05/06/2016
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement